Comparing the current results to its competitors, Evolent Health Inc reported Revenue increase in the 2 quarter 2026 by 46.86 % year on year. The sales growth was above Evolent Health Inc 's competitors' average revenue growth of 2.85 %, achieved in the same quarter.
Evolent Health Inc , slower than the average decrease reported by the company's competitors of -1.18 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -1.18 %
Evolent Health Inc 's Comment on Competition and Industry Peers
The company operates in a fragmented and competitive market characterized by rapidly evolving technology standards and customer requirements. Competitors include smaller niche firms as well as large, well-financed, and technologically advanced organizations. Competition factors include the breadth, depth, and quality of product and service offerings; the ability to deliver clinical, financial, and operational performance improvements; service quality and reliability; ease of use; brand recognition; and integration with existing technology. The company has expanded both organically and through acquisitions focused on specialties such as oncology, cardiology, radiology, musculoskeletal, physical medicine, and genetics care. It maintains partnerships with entities including an integrated delivery system in Pittsburgh, Pennsylvania, and The Advisory Board Company to support providers in adopting value-based business models. The company also engages in strategic acquisitions, investments, and divestitures to broaden its offerings and address partner demands for comprehensive solutions.
International Business Machines Corporation Share Performance
-23.09%
This Quarter
International Business Machines Corporation
Profile
International Business Machines Corporation (IBM) operates on a business model centered around delivering comprehensive technology products and services to enterprises globally, focusing on software, hardware, cloud computing, artificial intelligence, and consulting. Through these offerings, IBM seeks to enhance organizational efficiency, foster innovation, and support clients in achieving their digital transformation objectives.
Domo Inc's business model revolves around providing a cloud-based platform that allows organizations to easily access and analyze their data in real-time, enabling better decision-making and driving business growth. By offering a comprehensive suite of tools for data integration, visualization, and collaboration, Domo helps companies gain valuable insights and understand their performance across various departments and functions.
Sources:
Evolent Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Evolent Health Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
